GemVax&KAEL Co.,Ltd. (KOSDAQ: 082270)

Market Cap	549.57B
Revenue (ttm)	62.73B
Net Income (ttm)	-53.33B
Shares Out	39.68M
EPS (ttm)	-1,348.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,996
Open	13,930
Previous Close	13,930
Day's Range	13,690 - 14,090
52-Week Range	9,060 - 23,500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About GemVax&KAEL Co.,Ltd.

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1998
• Employees: 186
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082270

Financial Performance

In 2023, GemVax&KAEL Co.,Ltd.'s revenue was 72.21 billion, a decrease of -4.74% compared to the previous year's 75.80 billion. Losses were -27.18 billion, 38.6% more than in 2022.